|
Volumn 69, Issue 3, 2002, Pages 237-244
|
Respiratory allergy
|
Author keywords
Allergic rhinitis; Asthma; Atopy; Respiratory allergy
|
Indexed keywords
ACRIVASTINE;
ALLERGEN;
ANTIHISTAMINIC AGENT;
ANTIINFLAMMATORY AGENT;
ASTEMIZOLE;
AZELASTINE;
BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;
BRONCHODILATING AGENT;
CETIRIZINE;
CORTICOSTEROID;
CROMOGLYCATE DISODIUM;
DECONGESTIVE AGENT;
EBASTINE;
FEXOFENADINE;
IPRATROPIUM BROMIDE;
KETOCONAZOLE;
LEUKOTRIENE RECEPTOR BLOCKING AGENT;
LEVOCABASTINE;
LONG ACTING DRUG;
LORATADINE;
MACROLIDE;
NEDOCROMIL;
SODIUM CHLORIDE;
STEROID;
TERFENADINE;
THEOPHYLLINE;
ALLERGIC RHINITIS;
ASTHMA;
CLINICAL FEATURE;
CLINICAL TRIAL;
COMORBIDITY;
CONFERENCE PAPER;
DISEASE ASSOCIATION;
DISEASE SEVERITY;
DRUG EFFICACY;
DRUG SAFETY;
HEART ARRHYTHMIA;
HUMAN;
IMMUNOTHERAPY;
INTRACUTANEOUS TEST;
NOSE IRRITATION;
PATHOPHYSIOLOGY;
PATIENT CARE;
PATIENT REFERRAL;
PRICK TEST;
QUALITY OF LIFE;
RISK BENEFIT ANALYSIS;
RISK FACTOR;
SEDATION;
XEROSTOMIA;
|
EID: 0036212941
PISSN: 00195456
EISSN: None
Source Type: Journal
DOI: 10.1007/BF02734233 Document Type: Conference Paper |
Times cited : (4)
|
References (52)
|